A retrospective study evaluating safety of same-day pegfilgrastim administration and incidence of cystitis and ureteritis in patients with metastatic castration resistant prostate cancer treated with cabazitaxel ± carboplatin.
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2016
At a glance
- Drugs Pegfilgrastim (Primary) ; Cabazitaxel; Carboplatin
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 09 Aug 2016 New trial record